Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Psychiatric Decompensation During the COVID-19 Pandemic: A Literature Review and Case Series PDF $40.00
$40.00
× Placeholder Resistant Depression in a Patient With Polycythemia Vera Treated With Electroconvulsive Therapy PDF $40.00
$40.00
× Placeholder Prevalence and Predictors of Benzodiazepine Monotherapy in Patients With Depression: A National Cross-Sectional Study PDF $40.00
$40.00
× Placeholder Exercise as an Augmentation Treatment for Nonremitted Major Depressive Disorder: A Randomized, Parallel Dose Comparison PDF $40.00
$40.00
× Placeholder Controversies in the Diagnosis and Treatment of Severe Depression PDF $40.00
$40.00
× Placeholder A Randomized, Observer-Blind, Controlled Trial of the Traditional Chinese Medicine Yi-Gan San for Improvement of Behavioral and Psychological Symptoms and Activities of Daily Living in Dementia Patients PDF $40.00
$40.00
× Placeholder Vitamins B12, B6, and Folic Acid for Onset of Depressive Symptoms in Older Men: Results From a 2-Year Placebo-Controlled Randomized Trial PDF $40.00
$40.00
× Placeholder Inflammation and Improvement of Depression Following Electroconvulsive Therapy in Treatment-Resistant Depression PDF $40.00
$40.00
× Placeholder Effects of Olanzapine and Risperidone on Glucose Metabolism and Insulin Sensitivity in Chronic Schizophrenic Patients With Long-Term Antipsychotic Treatment: A Randomized 5-Month Study PDF $40.00
$40.00
× Placeholder Clinical Effects of Buspirone in Social Phobia: A Double-Blind Placebo-Controlled Study PDF $40.00
$40.00
× Placeholder Antidepressant Medication Management and Health Plan Employer Data Information Set (HEDIS) Criteria: Reasons for Nonadherence PDF $40.00
$40.00
× Placeholder Mefloquine Increases the Risk of Serious Psychiatric Events During Travel Abroad: A Nationwide Case-Control Study in the Netherlands PDF $40.00
$40.00
× Placeholder Declining Benzodiazepine Use in Veterans With Posttraumatic Stress Disorder PDF $40.00
$40.00
× Placeholder Risperidone and Paroxetine Given Singly and in Combination for Bipolar Depression PDF $40.00
$40.00
× Placeholder Role of Minocycline as an Adjunct Neuroinflammatory Modulator in Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials PDF $40.00
$40.00
× Placeholder Effects of Venlafaxine on Blood Pressure: A Meta-Analysis of Original Data From 3744 Depressed Patients PDF $40.00
$40.00
× Placeholder Electroconvulsive Therapy and Cardiovascular Complications in Patients Taking Trazodone for Insomnia PDF $40.00
$40.00
× Placeholder Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study PDF $40.00
$40.00
× Placeholder Access to Psychotropic Medication via Prescription Is Associated With Choice of Psychotropic Medication as Suicide Method: A Retrospective Study of 27,876 Suicide Attempts PDF $40.00
$40.00
× Placeholder Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report PDF $40.00
$40.00
× Placeholder Pharmacoeconomic Analysis of Sertraline Treatment of Depression in Patients With Unstable Angina or a Recent Myocardial Infarction PDF $40.00
$40.00
× Placeholder Augmentation of Antidepressants With Atypical Antipsychotic Medications for Treatment-Resistant Major Depressive Disorder: A Meta-Analysis PDF $40.00
$40.00
× Placeholder Rivastigmine From Capsules to Patch: Therapeutic Advances in the Management of Alzheimer's Disease and Parkinson's Disease Dementia PDF $40.00
$40.00
× Placeholder Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease PDF $40.00
$40.00
× Placeholder Endpoints in Preclinical Alzheimer's Disease Trials PDF $40.00
$40.00
× Placeholder The Impact of Attempted Suicide on the Symptoms and Course of Mood Disorders PDF $40.00
$40.00
× Placeholder Prediction of Suicidal Behavior in Clinical Research by Lifetime Suicidal Ideation and Behavior Ascertained by the Electronic Columbia-Suicide Severity Rating Scale PDF $40.00
$40.00
× Placeholder Effectiveness of Pharmacotherapy for Body Dysmorphic Disorder: A Chart-Review Study PDF $40.00
$40.00
× Placeholder Do Comorbid Personality Disorders Moderate Panic-Focused Psychotherapy? An Exploratory Examination of the American Psychiatric Association Practice Guideline PDF $40.00
$40.00
× Placeholder The Impact of Anxiety, Depression, and Suicidality on Quality of Life and Functional Status of Patients With Congestive Heart Failure and Hypertension: An Observational Cross-Sectional Study PDF $40.00
$40.00
× Placeholder Partial Compliance and Patient Consequences in Schizophrenia: Our Patients Can Do Better. PDF $40.00
$40.00
× Placeholder Early Prediction of Clinical Response in Schizophrenia Patients Receiving the Atypical Antipsychotic Zotepine PDF $40.00
$40.00
× Placeholder Cocaine as a Risk Factor for Neuroleptic-Induced Acute Dystonia PDF $40.00
$40.00
× Placeholder Do Efficacy and Effectiveness Samples Differ in Antidepressant Treatment Outcome? An Analysis of Eligibility Criteria in Randomized Controlled Trials PDF $40.00
$40.00
× Placeholder The Association Between Income and Distress, Mental Disorders, and Suicidal Ideation and Attempts: Findings From the Collaborative Psychiatric Epidemiology Surveys PDF $40.00
$40.00
× Placeholder Is Baseline Medication Resistance Associated With Potential for Relapse After Successful Remission of a Depressive Episode With ECT? Data From the Consortium for Research on Electroconvulsive Therapy (CORE) PDF $40.00
$40.00
× Placeholder Who Has the Ability to Consent? PDF $40.00
$40.00
× Placeholder Effects of Atypical Antipsychotics on the Syndromal Profile in Treatment-Resistant Schizophrenia PDF $40.00
$40.00
× Placeholder Excessive Antipsychotic Dosing in 2 U.S. State Hospitals PDF $40.00
$40.00
× Placeholder Central and Extrapontine Myelinolysis in the Setting of Hyperglycemia PDF $40.00
$40.00
× Placeholder Aromatherapy as a Safe and Effective Treatment for the Management of Agitation in Severe Dementia: The Results of a Double-Blind, Placebo-Controlled Trial With Melissa PDF $40.00
$40.00
× Placeholder Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study PDF $40.00
$40.00
× Placeholder Double-Blind Crossover Study of the Cognitive Effects of Lorazepam in Healthy Apolipoprotein E (APOE)-ε4 Carriers PDF $40.00
$40.00
× Placeholder Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort Study PDF $40.00
$40.00
× Placeholder Behavioral Treatment of Chronic Insomnia in Psychiatrically Ill Patients PDF $40.00
$40.00
× Placeholder Duloxetine Treatment of Dysthymia and Double Depression: An Open-Label Trial PDF $40.00
$40.00
× Placeholder Higher Baseline Proinflammatory Cytokines Mark Poor Antidepressant Response in Bipolar Disorder PDF $40.00
$40.00
× Placeholder A Case of Balint Syndrome Due to Left Basal Ganglia Hemorrhagic Stroke: Exploring the Pathogenesis Through Parietal Lobe Circuits PDF $40.00
$40.00
× Placeholder Efficacy and Response Time to Sertraline Versus Fluoxetine in the Treatment of Unipolar Major Depressive Disorder PDF $40.00
$40.00
× Placeholder Effects of Pharmacist-Led Dementia Care Round Interventions on the Use of Sleep Medications PDF $40.00
$40.00
× Placeholder The Effectiveness of Olanzapine, Risperidone, Quetiapine, and Ziprasidone as Augmentation Agents in Treatment-Resistant Major Depressive Disorder PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $2,040.00
Total $2,040.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe